SCHEMBL7211344

SCHEMBL7211344

CCCC[C@@]1(O)[C@H](O)[C@@H](CO)O[C@]1(n1cnc2c(=O)[nH]c(N)nc21)[SiH](c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PNP P00491 3/20 0.38
TK1 P04183 1/20 0.38
XDH P47989 1/20 0.38
HPGD P15428 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36
HINT1 P49773 4/20 0.36
ADORA3 P0DMS8 1/20 0.35
HPRT1 P00492 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34
EDNRA P25101 1/20 0.34
HTR2A P28223 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
HBB P68871 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7211289 0.85 KDM4E (0.43) TK1
SCHEMBL6753292 0.80 TK1 (0.42) PNPTK1HPGDHINT1ADORA3
SCHEMBL4949400 0.77 TK2 (0.36) TK1
SCHEMBL6889007 0.76 TK1 (0.43) PNPTK1HPGDHINT1ADORA3
SCHEMBL28199755 0.74 ADORA3 (0.40) PNPTK1XDHHPGDHINT1
SCHEMBL8863836 0.73 ADORA3 (0.41) PNPTK1HPGDHINT1ADORA3
SCHEMBL28167650 0.73 ADORA3 (0.42) PNPTK1HPGDHINT1ADORA3
SCHEMBL1964956 0.73 TK1 (0.46) PNPTK1XDHHPGDHINT1
SCHEMBL28293070 0.73 ADORA3 (0.41) PNPTK1HPGDHINT1ADORA3
SCHEMBL8840773 0.73 TK1 (0.43) PNPTK1HPGDHINT1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0977767-A4 AMINOOXY-MODIFIED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS INC (US) 2003-04-23 EP disclosed
EP-1102783-A4 AMINOOXY-MODIFIED NUCLEOSIDIC COMPOUNDS AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM ISIS PHARMACEUTICALS INC (US) 2002-07-31 EP disclosed
EP-1102783-A1 AMINOOXY-MODIFIED NUCLEOSIDIC COMPOUNDS AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM ISIS PHARMACEUTICALS, INC. (US) 2001-05-30 EP disclosed
WO-2000008042-A1 AMINOOXY-MODIFIED NUCLEOSIDIC COMPOUNDS AND OLIGOMERIC COMPOUNDS PREPARED THEREFROM ISIS PHARMACEUTICALS, INC. (US) 2000-02-17 WO disclosed
WO-2000008214-A1 OLIGONUCLEOTIDE ANALOGS HAVING MODIFIED DIMERS ISIS PHARMACEUTICALS, INC. (US) 2000-02-17 WO disclosed
EP-0977767-A1 AMINOOXY-MODIFIED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 2000-02-09 EP disclosed
WO-1998035978-A9 AMINOOXY-MODIFIED OLIGONUCLEOTIDES 1999-01-14 WO disclosed
WO-1998035978-A1 AMINOOXY-MODIFIED OLIGONUCLEOTIDES ISIS PHARMACEUTICALS, INC. (US) 1998-08-20 WO disclosed